EMMALINE SHELNUTT: Open Payments
NPI 1184396319 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 50 payments from 12 companies in 2025. Trend: 2023 $639 · 2024 $657 · 2025 $1,333
Food & beverage: $1,253Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $365 |
| UCB, Inc. | 9 | $187 |
| SK Life Science, Inc. | 9 | $150 |
| Alexion Pharmaceuticals, Inc. | 1 | $134 |
| Lundbeck LLC | 1 | $120 |
| ABBVIE INC. | 4 | $107 |
| PFIZER INC. | 3 | $63 |
| Neurelis, Inc. | 3 | $53 |
| Biogen, Inc. | 2 | $49 |
| Eisai Inc. | 2 | $45 |
Products named: Briviact, ULTOMIRIS, VYEPTI, QULIPTA, LEQEMBI, NURTEC ODT, VALTOCO, Ocrevus Zunovo.
Industry payments across VA — which companies pay providers there.
